These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 21785099)

  • 1. Radiofrequency ablation combined with chemoembolization: treatment of recurrent hepatocellular carcinomas after hepatectomy.
    Takaki H; Yamakado K; Sakurai H; Nakatsuka A; Shiraki K; Isaji S; Takeda K
    AJR Am J Roentgenol; 2011 Aug; 197(2):488-94. PubMed ID: 21785099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subphrenic versus nonsubphrenic hepatocellular carcinoma: combined therapy with chemoembolization and radiofrequency ablation.
    Yamakado K; Nakatsuka A; Takaki H; Sakurai H; Isaji S; Yamamoto N; Shiraki K; Takeda K
    AJR Am J Roentgenol; 2010 Feb; 194(2):530-5. PubMed ID: 20093620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study.
    Kang SG; Yoon CJ; Jeong SH; Kim JW; Lee SH; Lee KH; Kim YH
    J Vasc Interv Radiol; 2009 Dec; 20(12):1570-7. PubMed ID: 19879777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm.
    Takaki H; Yamakado K; Uraki J; Nakatsuka A; Fuke H; Yamamoto N; Shiraki K; Yamada T; Takeda K
    J Vasc Interv Radiol; 2009 Feb; 20(2):217-24. PubMed ID: 19097810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival with up to 10-year follow-up after combination therapy of chemoembolization and radiofrequency ablation for the treatment of hepatocellular carcinoma: single-center experience.
    Fujimori M; Takaki H; Nakatsuka A; Uraki J; Yamanaka T; Hasegawa T; Shiraki K; Takei Y; Sakuma H; Yamakado K
    J Vasc Interv Radiol; 2013 May; 24(5):655-66. PubMed ID: 23428356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment?
    Shibata T; Isoda H; Hirokawa Y; Arizono S; Shimada K; Togashi K
    Radiology; 2009 Sep; 252(3):905-13. PubMed ID: 19567647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone.
    Kim JW; Kim JH; Won HJ; Shin YM; Yoon HK; Sung KB; Kim PN
    Eur J Radiol; 2012 Mar; 81(3):e189-93. PubMed ID: 21353417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach.
    Kim HO; Kim SK; Son BH; Yoo CH; Hong HP; Cho YK; Kim BI
    Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):591-6. PubMed ID: 20007075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for distant recurrence of HCV-related hepatocellular carcinoma after radiofrequency ablation combined with chemoembolization.
    Fuke H; Sugimoto K; Shiraki K; Tanaka J; Beppu T; Yoneda K; Yamamoto N; Ito K; Takaki H; Nakatsuka A; Yamakado K; Takeda K; Takei Y
    Aliment Pharmacol Ther; 2008 Jun; 27(12):1253-60. PubMed ID: 18221404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy of chemoembolization and radiofrequency ablation for the treatment of hepatocellular carcinoma in the caudate lobe.
    Fujimori M; Takaki H; Nakatsuka A; Uraki J; Yamanaka T; Hasegawa T; Shiraki K; Takei Y; Yamakado K
    J Vasc Interv Radiol; 2012 Dec; 23(12):1622-8. PubMed ID: 23177108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: comparative effectiveness of treatment modalities.
    Ho CM; Lee PH; Shau WY; Ho MC; Wu YM; Hu RH
    Surgery; 2012 May; 151(5):700-9. PubMed ID: 22284764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transcatheter arterial chemoembolization plus percutaneous thermal ablation in large hepatocellular carcinoma: clinical observation of efficacy and predictors of prognostic factors].
    Fan WZ; Yang JY; Lü MD; Xie XY; Yin XY; Huang YH; Kuang M; Li HP; Xu HX; Li JP
    Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(31):2190-4. PubMed ID: 22094036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment strategy for early hepatocellular carcinomas: comparison of radiofrequency ablation with or without transcatheter arterial chemoembolization and surgical resection.
    Tashiro H; Aikata H; Waki K; Amano H; Oshita A; Kobayashi T; Tanimoto Y; Kuroda S; Tazawa H; Chayama K; Asahara T; Ohdan H
    J Surg Oncol; 2011 Jul; 104(1):3-9. PubMed ID: 21656523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
    Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
    J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
    Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
    Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial.
    Peng ZW; Zhang YJ; Liang HH; Lin XJ; Guo RP; Chen MS
    Radiology; 2012 Feb; 262(2):689-700. PubMed ID: 22157201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma.
    Hoffmann R; Rempp H; Syha R; Ketelsen D; Pereira PL; Claussen CD; Clasen S
    Eur J Radiol; 2014 Oct; 83(10):1793-8. PubMed ID: 25052871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous ablative therapies of recurrent hepatocellular carcinoma after hepatectomy: proposal of a prognostic model.
    Yin XY; Xie XY; Lu MD; Kuang M; Liu GJ; Xu ZF; Xu HX; Wang Z
    Ann Surg Oncol; 2012 Dec; 19(13):4300-6. PubMed ID: 22766980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
    Guo YJ; Huang WS; Zhou B; Chen JW; Cai MY; Qian JS; Huang MS; Shan H; Zhu KS
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2627-30. PubMed ID: 24360041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.